A clinical prognostic model related to T cells based on machine learning for predicting the prognosis and immune response of ovarian cancer
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82371659)
- Nantong University (YJXYY202204-YS1303)
- Guangzhou Municipal Science and Technology Program key projects (2024A03J1087)
- Guangzhou Municipal Science and Technology Program key projects (2024A04J4164)
- National Key Research and Development Program of China (2022YFC2702500)
This publication has 53 references indexed in Scilit:
- Identification and biotin receptor-mediated activity of a novel seleno-biotin compound that inhibits viability of and induces apoptosis in ovarian cancer cellsChemico-Biological Interactions, 2022
- An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinomaCancer Immunology, Immunotherapy, 2020
- Beclin 1, Bcl-2 and Autophagy2019
- Comprehensive Integration of Single-Cell DataCell, 2019
- Androgen Receptor Function and Androgen Receptor–Targeted Therapies in Breast CancerJAMA Oncology, 2017
- Role of the tumor microenvironment in regulating apoptosis and cancer progressionCancer Letters, 2016
- Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian CancerCell, 2016
- A Systematic Review of Symptoms for the Diagnosis of Ovarian CancerAmerican Journal of Preventive Medicine, 2016
- Differential Remodeling of Actin Cytoskeleton Architecture by Profilin Isoforms Leads to Distinct Effects on Cell Migration and InvasionCancer Cell, 2012
- Profilin‐1 overexpression upregulates PTEN and suppresses AKT activation in breast cancer cellsJournal of Cellular Physiology, 2008